Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile”

395 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 395 results

Large-scale testing (Phase 3)UnknownNCT06107569
What this trial is testing

Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma

Who this might be right for
Clostridium Difficile Infections
Hospital Universitario Evangelico de Curitiba 24
Not applicableLooking for participantsNCT07374094
What this trial is testing

Clostridioides Difficile: Understanding Responses and Treatment Effects

Who this might be right for
Clostridioides Difficile Infection
Umeå University 200
Not applicableUnknownNCT03053505
What this trial is testing

A Novel Faecal Microbiota Transplantation System for Treatment of Primary and Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Sejtterapia Kozpont Kft. 150
Early research (Phase 1)Study completedNCT01704937
What this trial is testing

Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum

Who this might be right for
Clostridium Difficile Infection
Massachusetts General Hospital 20
Not applicableStudy completedNCT01957761
What this trial is testing

Molecular Epidemiology of Clostridium Difficile Infections in Children

Who this might be right for
Clostridium Difficile Infections
Ann & Robert H Lurie Children's Hospital of Chicago 132
Post-approval studies (Phase 4)Ended earlyNCT03756454
What this trial is testing

Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.

Who this might be right for
Clostridia Difficile ColitisClostridium; Sepsis
Michael E Villarreal, MD 5
Post-approval studies (Phase 4)Ended earlyNCT00177970
What this trial is testing

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
University of Pittsburgh 14
Testing effectiveness (Phase 2)Study completedNCT03621657
What this trial is testing

The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation

Who this might be right for
Clostridium Difficile InfectionC.Difficile DiarrheaCDI
University of Wisconsin, Madison 1
Early research (Phase 1)UnknownNCT02134392
What this trial is testing

Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection

Who this might be right for
Clostridium Difficile
Jonathan Gisser 15
Not applicableStudy completedNCT01560832
What this trial is testing

Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region

Who this might be right for
Clostridium Difficile Infection
Yonsei University 188
Large-scale testing (Phase 3)Looking for participantsNCT05266807
What this trial is testing

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence

Who this might be right for
Clostridioides Difficile Infection
Benoit Guery 100
Early research (Phase 1)Study completedNCT02106338
What this trial is testing

Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.

Who this might be right for
Clostridium Difficile Infection
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableUnknownNCT01873872
What this trial is testing

Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics

Who this might be right for
Development of Clostridium Difficile Associated Diarrhea
St. Vincent's East, Birmingham, Alabama 120
Large-scale testing (Phase 3)Ended earlyNCT04802837
What this trial is testing

Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects

Who this might be right for
Clostridioides Difficile Infection
Summit Therapeutics 2
Early research (Phase 1)Looking for participantsNCT05911997
What this trial is testing

MTC Versus FMT in for RCDI

Who this might be right for
Clostridiodies Difficile Infections
Icahn School of Medicine at Mount Sinai 60
Early research (Phase 1)Study completedNCT02835118
What this trial is testing

Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 30
Testing effectiveness (Phase 2)Study completedNCT02117570
What this trial is testing

Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Who this might be right for
Clostridium Difficile Associated Disease
Pfizer 185
Testing effectiveness (Phase 2)Study completedNCT07496502
What this trial is testing

Effect of Oral Microbiota on MDRO Decolonization

Who this might be right for
Clostridioides Difficile InfectionDrug Resistance, BacterialGastrointestinal Microbiome+2 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 42
Not applicableStudy completedNCT03117582
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics

Who this might be right for
Clostridium Difficile
University of North Carolina, Chapel Hill 34
Early research (Phase 1)Study completedNCT01706367
What this trial is testing

Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years

Who this might be right for
Clostridium Difficile Associated Disease
Pfizer 192
Load More Results